Sarepta Therapeutics, Inc. Skyrocketed

Sarepta Therapeutics, Inc. (SRPT:NASDAQ) soared at $132.05, representing a gain of 31.4%. On Thu 12 Dec 19, SRPT:NASDAQ touched a New 2-Week Low of $100.47. The stock appeared on our News Catalysts scanner on Fri 13 Dec 19 at 04:02 PM in the 'BIOTECH' category. From Thu 21 Nov 19, the stock recorded 57.14% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Sarepta Therapeutics, Inc. (SRPT:NASDAQ)
Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
Top 10 Gainers:
- Franchise Group, Inc. (FRG:NASDAQ), 49.13%
- Pacific Coast Oil Trust (ROYT:NYSE), 45.66%
- Lianluo Smart Limited (LLIT:NASDAQ), 41.46%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 34.73%
- China Ceramics Co., Ltd. (CCCL:NASDAQ), 32.5%
- Sarepta Therapeutics, Inc. (SRPT:NASDAQ), 31.43%
- NantKwest, Inc. (NK:NASDAQ), 30.91%
- ContraFect Corporation (CFRX:NASDAQ), 29.47%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 28.94%
- Cohen & Company Inc. (COHN:NYSEMKT), 27.82%